Clinical and Translational Gastroenterology (CTG)
Instructions for Authors (this page)

MISSION

To improve the health and well-being of individuals worldwide impacted by digestive disorders.

AIMS AND SCOPE
Clinical and Translational Gastroenterology (CTG), published on behalf of the American College of Gastroenterology (ACG), is a double-blind peer-reviewed, open access, online journal dedicated to innovative clinical work in the field of gastroenterology, pancreatology, and hepatology. CTG seeks to promptly publish and broadly disseminate important clinical care insights and significant scientific discoveries that impact the prevention, diagnosis, and treatment of digestive disorders. CTG hopes to fulfill an unmet need for clinicians and scientists by welcoming novel cohort studies, early-phase clinical trials, qualitative and quantitative epidemiologic research, hypothesis-generating research, and studies of novel mechanisms and methodologies including public health interventions. CTG also welcomes hypothesis-generating studies, methods papers, and translational research with clear applications to human physiological processes or diseases involving the gastrointestinal system. CTG adopts the National Institutes of Health’s (NIH) definition of translational research:

Translational research includes two areas of translation. One is the process of applying discoveries generated during research in the laboratory, and in preclinical studies, to the development of trials and studies in humans. The second area of translation concerns research aimed at enhancing the adoption of best practices in the community. Cost-effectiveness of prevention and treatment strategies is also an important part of translational science1.

This definition therefore requires the application of findings to human subjects, either directly or indirectly. Basic science research, particularly research involving animal models or in-vitro work, is best reported elsewhere. CTG expands the scope of translational research to include public health dimensions that impact the human experience. CTG devotes itself to publishing timely medical research in gastroenterology, pancreatology and hepatology with:

MANUSCRIPT SUBMISSION
Submissions are not accepted via email. Manuscripts must be submitted online at https://www.editorialmanager.com/ctg

First-time Users: Please click the Register button in the main menu and enter the requested information. Upon successful registration, you will be sent an email indicating your username and password. Save a copy of this information for future reference. Note: If you have received an email from us with an assigned user ID and password, or if you are a repeat user, do not register again. Once you have an assigned ID and password, you do not need to re-register, even if your role changes (that is, author, reviewer, or editor). Authors please click the login button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the system instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact the Editorial Office (or click on the 'Contact Us' link in the header menu).

ETHICAL AND LEGAL CONSIDERATIONS
A submitted manuscript must be an original contribution not previously published (except as an abstract), must not be under consideration for publication elsewhere, and, if accepted, it must not be published elsewhere in similar form, in any language, without the consent of Wolters Kluwer. The Journal follows the ICJME recommendations for authorship. Any person listed as an author is expected to have participated in the study to a significant extent. Although editors and reviewers make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.

Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) is required for all studies involving people, medical records, and human tissues, and for all animal studies. For authors or investigators that do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be provided. Informed consent by participants should always be sought and documented in the Methods section. If not possible, an institutional review board must decide if this is ethically acceptable, and documentation of this decision must be included with the submission. In the main manuscript, a general IRB approval statement should be included. A more detailed statement that includes the name of the approving institution must be included on the title page.

Plagiarism Detection: CTG is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers, and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com. If a case of plagiarism comes to light after a paper is published, the Journal will conduct a preliminary investigation, utilizing the guidelines of the Committee on Publication Ethics. If plagiarism is proven, the journal will contact the author’s institute and funding agencies as appropriate. The paper containing the plagiarism may also be formally retracted or subject to correction.

Patient Anonymity and Informed Consent: Authors should remove patients' names and other identifying information from figures. If any identifying details appear in text, tables, and/or figures, the author must provide proof of informed consent obtained from the patient (i.e., a signed permission form). Photographs with bars placed over eyes of patients should NOT be used in publication. If they are used, permission from the patient is required. If the parents or guardian were unable to be located for their consent, a signed statement from the Chair of the Department or from the Institutional Review Board may be accepted. The statement must read: all attempts have been exhausted in trying to contact the parents or guardian for the purpose of attaining their consent to publish their information.

Conflicts of Interest: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest" and via the submission form in Editorial Manager.

Declaration of Funding Source: Acknowledgment of grants or financial support must be declared for all manuscripts. In addition, authors of all articles in which the effect of a drug, appliance, or treatment is evaluated must also acknowledge all support from the manufacturer of such drug, appliance, or treatment or its competitor. Authors of all articles, including review articles, editorials, and correspondence, must disclose any financial interests that might have an impact on the views expressed in the submission. The funding declaration must be included on the title page of the manuscript and via the submission form in Editorial Manager. Authors with nothing to declare should provide a statement to that effect. Manuscripts submitted without the required disclosures will be returned to the authors.

Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permission fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Wolters Kluwer. Contact the publication’s website of the content being reused and follow the instructions for contacting the permissions team. There is often a direct link to request permission through the online version of the article.

Clinical Trials: Original Research Articles of studies that prospectively assign human subjects to specific intervention or comparison groups and determine the relationship between an intervention and outcome are considered clinical trials. To ensure consistency with the guidelines of the Clinical Trial Registration Statement from the International Committee of Medical Journal Editors, all trials submitted to the Journal with patient enrollment commencing after January 1, 2009 must be registered in a public trials registry prior to enrollment of the first subject. The registry must incorporate free public access, and must be searchable, open to prospective registrants, and have not-for-profit management. The following information must be included in the registry: (1) unique identifying number, (2) statement of intervention(s), (3) hypothesis, definition of primary and secondary outcome measurements, eligibility criteria, target number of subjects, funding source, contact information for principal investigator, and dates of registration, start, and completion. Authors should provide the URL (website address) and trial identification number on the title page of the manuscript. This information will be published with the article.

Clinical trial reports should comply with the Consolidated Standards of Reporting Trials (CONSORT) and the checklist should be submitted at the end of the manuscript.

Reporting Clinical Trials Conducted by Pharmaceutical Companies: Please ensure that clinical trials sponsored by pharmaceutical companies follow the guidelines on Good Publication Practice (Committee on Publication Ethics). These guidelines aim to ensure that such trials are published in a responsible and ethical manner. The guidelines cover companies' responsibility to endeavor to publish results of all studies, companies' relations with investigators, measures to prevent redundant or premature publication, methods to improve trial identification, and the role of professional medical writers.

STAndards for the Reporting of Diagnostic accuracy studies (STARD checklist): If you are reporting a study that has assessed one or more diagnostic tests you must complete the STARD Statement, and paste it onto the end of your full manuscript.

STrengthening the Reporting of OBservational studies in Epidemiology (STROBE Statement): Reports of an observational cohort, case-control, or cross-sectional study must include the relevant STROBE Checklist at the end of the manuscript. Additional information can be found on the STROBE website.

Standards for QUality Improvement Reporting Excellence (SQUIRE statement): should be applied for quality improvement (QI) projects and those involving a detailed consensus process.

ARTICLE TYPES

Original Research Articles: Although the Editors do not impose page or word limits on articles, they reserve the right to request that any text and/or information deemed non-essential be published online as supplementary material to the main article. In general, limit full-length articles to 3,000 words, not including references, tables, or abstract. Include a structured abstract of 250 words or fewer and study highlights. All abstracts and main body of Original Research article manuscripts must include the following section headings:

Review Article (Narrative): CTG publishes substantive reviews on clinical and translational topics with value to clinicians. Special priority is given to emerging or rapidly evolving topics. All articles will be peer reviewed prior to consideration. Include an unstructured abstract of no more than 250 words. The main article should be not more than 3,000 words excluding references, figures and tables. The review should contain at least 2 and not more than 8 figures or tables. Authors of either narrative reviews or systematic reviews (see below) with financial conflicts of interest relevant to the topic(s) should make every effort to present a fair and balanced review. In the setting of potential conflicts of interest, the Editorial Board may summarily reject reviews perceived as biased.

Review Article (Systematic Review and Meta Analysis): CTG publishes high-quality systematic reviews and meta-analyses in all topics of gastroenterology, pancreatology and hepatology. All articles will be peer reviewed prior to consideration. The literature search should be conducted in MEDLINE and EMBASE at minimum. If controlled trials are sought, the Cochrane Central Register of Controlled Trials should be searched as well. The risk of bias of included studies should be systematically assessed, reported and discussed. Include a structured abstract of not more than 250 words. The main article should be not more than 3,000 words excluding references, figures and tables. The review should contain at least 2 and not more than 8 figures or tables.

A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist should be included at the end of the manuscript. Alternatively, the MOOSE checklist should be applied for meta-analyses of observational studies. A full list and index of reporting guidelines can be found at www.equator-network.org/library/. All can be downloaded as Word documents that can then be included at the end of the manuscript. 

The Clinician’s Toolbox: Understanding our Tests: This article type explores a single diagnostic test used in gastroenterology, pancreatology or hepatology. The manuscript should include an overview of the test, its indication(s), how it is performed, the performance characteristics (sensitivity, specificity, positive- and negative-predictive values and likelihood ratios), conditions that make the test results inaccurate and how to manage such results, how clinicians should incorporate the testing into clinical care or research studies, a brief discussion of any alternative tests that may replace or complement the test, and relevant billing and cost information. Published literature should be cited to support the information provided and relevant studies that examined the test’s utility and accuracy should be included. Figures are encouraged. Authors should not have financial conflicts of interest related to the test. In general, limit the main text to 3,000 words, not including references, tables, or abstract. Please include an unstructured abstract summarizing the content of the article.

Brief Report: The Editors welcome brief reports of novel findings and/or highly-impactful preliminary data deemed likely to alter clinical care or foster a new direction in research. As such, CTG expects to publish only a very small number of these articles each year. Like with our Original Research format, only studies with human subjects or with human-derived samples are appropriate. Include the following sections: Introduction, Methods, Results, Discussion (see Original Research Articles above for more details). Manuscripts should be limited to 1000 words or less, excluding references and abstract. Include a structured abstract of 150 words or less, 15 references or less, and 3 or less total tables/figures/images. Include a title page with COI information, but no study highlights.

Editorial: Editorials will be paired with select articles and solicited at the provisional acceptance of an article. Unsolicited Editorials will not be considered. To submit a perspective for consideration, please see the Correspondence section. Editorials require an unstructured abstract of 100 words or less and limited to 1,000 words, excluding references.

Correspondence: Correspondence should regard published articles in CTG, or be a general comment about an issue relevant to the field. Peer review of letters will be at the discretion of the Editor. Correspondence must cite the article on which it comments, should be no more than 500 words, have 5 or less references, and no abstract. Please include a complete title page with full conflict of interest and funding disclosures as a separate file. This is not a forum for authors to publish their own original research or data, and CTG does not publish case reports. Note that article processing charges do not apply to Correspondence.

MANUSCRIPT PREPARATION
Manuscripts must be in English and typed double-spaced. The American Medical Association Manual of Style (10th ed.), Stedman’s Medical Dictionary (28th ed.), and Merriam-Webster’s Collegiate Dictionary (11th ed.) should be used as standard references. The journal follows the International Committee of Medical Journal Editors’ Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Manuscripts not prepared according to the Instructions to Authors will be returned to the author(s) without review.

English Language: Concise, clearly written articles are more likely to be accepted for publication in the CTG. Authors whose first language is not English are strongly encouraged to ask a native English-speaking colleague or a professional author’s editor, preferably with knowledge in the subject matter contained in the manuscript, to edit their manuscript before submission. Please note that the use of a language editing service is not a requirement for publication in this journal and does not imply or guarantee that the article will be selected for peer review or accepted. A list of editing services is available at https://wkauthorservices.editage.com.

Human Data Requirement: CTG requires that manuscripts describe work involving humans or human samples. If the manuscript lacks a human research component, the work must have immediate and direct translational applicability, which should be clearly communicated in the manuscript.

Cover Letter: In the cover letter, provide a statement of whether the paper was previously published in any language, including the abstract, and whether the paper is currently under consideration elsewhere for publication.

Title Page: The journal conducts a double-blind peer review process. The title page must include following: 1) the article title (150 characters or less); 2) all authors' names, degrees, affiliations, and locations; 3) the name and email address of the corresponding author; 4) the author(s) conflict of interest/study support items as noted below; 5) IRB approval statement

Author Conflict of Interest/Study Support: Authors submitting work for publication in the Journal, including those writing Correspondence, are required to submit a conflict of interest disclosure. Review of a submission for publication will not commence and publication will not be permitted unless and until disclosures are submitted. If there is no actual or potential conflict, the author must indicate such. On your title page, please include a section with the following headings:

Study Highlights: Only authors of original research Articles are required to include a Study Highlights section in their manuscript. The section should contain two headings: 1) WHAT IS KNOWN and 2) WHAT IS NEW HERE. The items under each heading should be bullet points that are very short, i.e., up to about 15 words.

WHAT IS KNOWN

WHAT IS NEW HERE

Visual Abstracts: Visual abstracts summarize an article’s main findings and may be published with the accepted article in the journal's online table of contents and/or used for promotion of your article. Authors of accepted articles should submit a visual abstract for publication with their manuscript. Please find a template with formatting instructions and some examples of previously published visual abstracts here.

Translated Abstracts: The Journal welcomes authors to submit a non-English language abstract as part of a submission. The authors must attest to the correct translation of the abstract and submit it using the visual abstract template [above].

Abbreviations: Write out the full term for each abbreviation at its first use in abstract, what is known, manuscript body, and in each table and figure legend unless it is a standard unit of measure. SD, HIV, and DNA do not need to be expanded.

Units: All measurements should be given in metric units.

Title Length: The manuscript title should have no more than 150 characters including spaces. Keywords for referencing should be included in the title. Do not use abbreviations, trade names of drugs or other products, or fancy/comical titles. The editors may request a new title prior to publication.

Abstract: Please refer to the table below for abstract requirements for various article types. Do not cite references in the abstract. Limit the use of abbreviations and acronyms. Write out the full term for abbreviations at first mention (e.g. celiac disease (CD)). Use the following subheads in your structured abstract: Introduction, Methods, Results, and Conclusions.

Keywords: List three to five keywords for your article.

Drugs, Devices, and Other Products: Use nonproprietary names of drugs, devices, and other products, unless the specific trade name is essential to the discussion. The trade name may appear once in the Abstract and once in the Introduction or Methods section, followed by the nonproprietary name, manufacturer, and manufacturer location in parentheses; all other mention of the product must use the generic name. Trade names of drugs and other products must not appear in the article title.

References: The reference list should only include works that are cited in the text, should be listed consecutively as they appear in the text, and should follow the AMA Manual of Style, 10th Edition. The authors are responsible for the accuracy of the references. Cite the references in text in the order of appearance. Cite unpublished data—such as papers submitted but not yet accepted for publication and personal communications, including email communications—in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names.

Sample References:
Journal Article
Rautava S, Lu L, Nanthakumar NN, et al. TGF-β2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NF-κB pathway. J Pediatr Gastroenterol Nutr 2012;54:630-8.

Online Article
7. Sullivan D. Major search engines and directories. SearchEngineWatch Web site. [URL]. Published May 8, 2011. Accessed July 13, 2012.

Entire Book
Ming S-C, Goldman H. Pathology of the Gastrointestinal Tract. Philadelphia: Lippincott Williams & Wilkins; 2008.

Book Chapter
Todd VR. Visual information analysis: frame of reference for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. Philadelphia: Lippincott Williams & Wilkins; 2017:205–56.

Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 2016. Updated March 29, 2016.

Figures:
Creating Digital Artwork

Digital Artwork Guideline Checklist

Remember

Tables: Cite tables consecutively in the text and number them in that order. Provide tables in Word format, either as separately labeled files or at the end of your main manuscript document. Each table must have a title. Use footnotes to define abbreviations and for other explanatory detail in a legend below the Tables. Tables should be self-explanatory and must supplement, rather than duplicate, the material in the text.

Supplemental Digital Content (SDC): Authors may submit supplemental digital content with a submission to enhance their article's text or include text, tables, and figures outside of the specified limits. All supplemental digital content is posted online only. One advantage of including material as SDC is that SDC has no limitation of space or length. SDC may include the following types of content: text documents--including very detailed methods--graphs, tables, figures, graphics, illustrations, audio, and video. Authors are encouraged to submit related but not essential tables (e.g., large tables of articles cited in a meta-analysis, or a large demographic table of a study population) as SDC.

Notes: All online-only materials will be subject to peer review and published at the editor discretion. Supplemental figures, legends, and tables must not appear in the main manuscript file. All legends should be kept with the image or table it refers to for reader access. SDC text will not be copyedited nor typeset. Submit content exactly as intended to be displayed (including legends). No errata will be written for SDC content. No patient-identifying information should be used in SDC unless written consent from the patient, the patient's parent/guardian has been obtained and is submitted with the manuscript. Copyright and Permission forms for article content including SDC must be provided at the time of submission.

Each piece of supplemental content should be uploaded in a separate file, labeled consecutively as Supplemental Digital Content, regardless of type. For example:

Cite all supplementary content consecutively in the text and independently from any figures or tables, including a sequential number, and provide a brief description of the supplementary content. For example:

To ensure a quality experience for those viewing supplemental digital content, it is suggested that authors submit supplemental digital files no larger than 10 MB each. Documents, graphs, and tables may be presented in any format. Figures, graphics, and illustrations should be submitted with the following file extensions: .tif, .eps, .ppt, .jpg, .pdf, .gif. Audio files should be submitted with the following file extensions: .mp3, .wma. Video files should be submitted with the following file extensions: .wmv, .mov, .mpg, .mpeg, .mp4. Video files should also be formatted with a 320 X 240-pixel minimum screen size. For more information, please review Wolters Kluwer's requirements for submitting supplemental digital content: http://links.lww.com/A142.

PEER REVIEW PROCESS

CTG currently utilizes the double-blind method of peer reviewing. The peer review process is handled entirely electronically through the Editorial Manager site. Peer reviewers are instructed to review the contents of the submission in a critical, unbiased, and timely fashion. They review all pieces of the submission, including the main text manuscript, as supplementary files, tables, and images. The title page with author names, affiliations, and IRB statement are blinded to the reviewers. The Editorial Board aims to have all Articles and Review Articles peer reviewed by two external reviewers in addition to one Associate Editor and the Editor-in-Chief. Editorials, and Correspondence are reviewed by an Associate Editor and the Editor in Chief, and sent for external peer review if needed.

Editors are excluded from the review process for any manuscript on which they are an author. Other Editors perform these duties in these situations. Authors may suggest peer reviewers during the submission process, but the Editorial Office does not guarantee that those peer reviewers will be invited for review, and peer review invitations are at the sole discretion of the Editorial Office and Editorial Board. The Editorial Board has the freedom to assess the peer reviews and decide either with or against the recommendations. Peer reviews are rated after each decision, and these ratings are used to refine the peer reviewer pool for future use. CTG also allows interested reviewers to include trainees in the peer review process as a way to foster expertise and train the next generation of reviewers.

OPEN ACCESS

License to Publish: At submission, all authors must certify their understanding of the open access requirement for CTG. In addition, the corresponding author must complete a license to publish form on behalf of all authors at the time of submission. A copy of the license form is made available to the corresponding author during the Editorial Manager submission process and can be uploaded with the manuscript files. Payment of article processing charges will be collected only upon acceptance of the manuscript.

Article Processing Charges: CTG is an open access, peer reviewed journal. For all accepted articles, the article processing charge (APC) will be required to allow perpetual unrestricted online access to the published article to readers globally, immediately upon publication. This fee is collected only upon acceptance of the manuscript. CTG uses a tiered APC system, where direct submissions by non-members of ACG are $2,800 USD, submissions by one or more members of ACG are $2,600 USD, and submissions transferred directly from the American Journal of Gastroenterology are $2,200 USD. Further instructions for payment will be provided by the editorial office upon acceptance, per your submission type. There are no submission, color, or page charges. Fees are collected through Wolters Kluwer’s payment site at https://wolterskluwer.qconnect.com.

Authors Retain Copyright: Authors retain their copyright for all articles published open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license.

Creative Commons License: Open access articles will be freely available to read, download and share from the time of publication. CTG provides authors the choice of applying one of the Creative Commons 4.0 licenses defined below. Questions regarding licenses can be directed to the Editorial Office.

Compliance with NIH and Other Research Funding Agency Accessibility Requirements: A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, Wolters Kluwer identifies to the National Library of Medicine (NLM) articles that require deposit and transmits the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The License to Publish provides the mechanism. Wolters Kluwer ensures that authors can fully comply with the public access requirements of major funding bodies worldwide.

FAQ for Open Access: http://www.wkopenhealth.com/openaccessfaq.php

AFTER ACCEPTANCE

Accepted Article: The publisher will place the PDF of your accepted paper on the Latest Articles page with the label “Accepted Manuscript.” After copyediting and typesetting, you’ll be given the chance to view your paper one final time before publication. Once you approve the typeset version the editorial office will place the article into an upcoming issue.

Electronic Page Proofs and Corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and marking the electronic page proofs. Corresponding author must provide an email address. The proof/correction process is done electronically.

It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Electronic proofs must be checked carefully and corrections returned within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.

Reprints: Authors will receive an email notification with a link to the order form soon after their article publishes in the journal (https://shop.lww.com/author-reprint). Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: 410.558.6234; E-mail: [email protected] with any questions.

CTG Summary of Article Type Parameters

Article Type

Abstract

Study Highlights

Text Limit

Image/Table Limit

Reference Limit

COI Statement

Article

Structured 250 words

Required

3000 words

8 total

No limit

Required

Review Article (Narrative)

Unstructured 250 words

No

3000 words

8 total

No limit

Required

Review Article (SR/MA)

Structured 250 words

No

3000 words

8 total

No limit

Required

Clinician's Toolbox

Unstructured 250 Words

No

3000 words

8 total

No Limit

Required

Brief Report

Structured 150 Words

No

1000 words

3 total

15

Required

Editorial

Unstructured 100 words

No

1000 words

2 total

10

Required

Correspondence

None

No

500 words

2 total

5

Required

PRE-SUBMISSION CHECKLIST
Please use the following checklist to decrease the likelihood that your manuscript will be returned:


  1. Title page: Provide details for all of the authors/co-authors and an email for the corresponding author on the title page. Verify that co-author names, titles, affiliations and degrees are accurate and current. 

  2. Conflict of Interest: Be sure to list all Conflicts of Interest on your title page in the format specified earlier in this guide, and enter into the Editorial Manager submission system where requested. 

  3. Manuscript length and formatting: Check that the length of the manuscript and abstract do not exceed the maximum word count and are formatted as per instructions to authors for each. See the Article Type chart for length and abstract guidelines. 

  4. Study highlights: For Articles, be sure to include the study highlights section as described earlier in this guide. 

  5. Figures: Do not embed figures in manuscript. Cite the figures in the text of the manuscript andprovide figure legends at the end of your manuscript. Check that the figures and supplementary figures are formatted as indicated in the instructions to authors. Each figure should be in a separate file (uploaded individually). 

  6. Tables: Include tables at the end of the main text of your manuscript. Tables must be in text format and not images embedded into the document. Cite the tables in the text of the manuscript and provide table legends. Check that the tables and supplementary tables are formatted as indicated in instructions to authors. 

  7. References: Make sure each reference is cited in the text, references are formatted per instructions to authors and the quantity does not exceed maximum for the article type. Double check the accuracy of each reference (spelling of names, page numbers, proper journal abbreviation, etc.) as any errors are the authors' responsibility. 

  8. Supplementary files and appendices: Make sure files are formatted per instructions to authors and cited in main text. Legends to figure(s) and/or table legend(s) should appear in the same file, or can be uploaded as separate supplementary digital content as needed. 

  9. Clinical trials: Include documentation that the project was registered in a public trials registry prior to enrollment of the first subject. Be sure you have complied with one of the appropriate reporting guidelines endorsed by the EQUATOR Network (i.e., CONSORT, PRISMA, STARD, SQUIRE, and MOOSE). More information may be found at http://www.equator-network.org and http://www.equator-network.org/library/. For studies falling into the categories covered by these checklists, authors need to submit a formal checklist at the end of the manuscript at the time of submission. This ensures faster review turnaround since many of the points on the checklist ensure improved ease of review. 

  10. Ethics: Make sure the necessary ethical approval/clearance or informed consent was obtained and is noted on the title page where applicable. 

  11. Permissions: If using previously published materials, include permission to re-use the material obtained from the copyright holder as Supplemental Data and acknowledge the source in your legend as indicated by the permission reuse terms. 

  12. Revised manuscripts: Include a point-by-point response to the comments of each reviewer in one separate file. Submit both a final and marked up revision showing all changes made with highlighting or track changes.

CONTACT INFORMATION
For all matters manuscript and peer review, contact:
Managing Editor
Clinical and Translational Gastroenterology
11333 Woodglen Drive, Suite 100
North Bethesda, MD 20852
Tel: 301-263-9000
Fax: 301-263-9025
Email: [email protected]

References

(http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-07-007.html.; accessed February 7, 2021).

http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html (Accessed 5/28/2021)